- Lung cancer is the leading cause of cancer-related deaths globally.
- Most lung cancer cases are not diagnosed until the advanced stage, lowering a person’s 5-year survival rate.
- Currently, the only screening available for lung cancer is a low-dose CT, which has some limitations.
- A cancer genomics company says it has developed a blood test for the detection of early-stage lung cancer.
Lung cancer is the
The
Currently, the only screening available for lung cancer is a low-dose computed tomography (CT) scan. However, CT scans can sometimes lead to
Now, a new way to find lung cancer at its early stages is in the works.
At this year’s European Society for Medical Oncology annual congress, initial findings were presented for a new blood test for the detection of early-stage lung cancer.
The research hasn’t been published yet in a peer-reviewed journal.
Developed by cancer genomics company Personalis Inc., the new test — called the NeXT Personal ctDNA assay — can detect small traces of
“The NeXT Personal technology leverages whole genome sequencing and advanced noise suppression with NeXT SENSE technology to…
Read the full article here